M. Kazma
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 8
-
- Antibiotic Use and Resistance 3
- Co-authors
- Yehuda CarmeliT. KotlovskyShiri Navon‐VeneziaDavid A. SchwartzVered SchechnerMitchell J. SchwaberHagit MishaliChristine Lammens
In The Last Decade
M. Kazma
10 papers receiving 420 citations
Peers
Comparison fields: 5 of 51
- Molecular Medicine 347
- Applied Microbiology and Biotechnology 113
- Endocrinology 155
- Clinical Biochemistry 82
- Critical Care and Intensive Care Medicine 24
Countries citing papers authored by M. Kazma
This map shows the geographic impact of M. Kazma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kazma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kazma more than expected).
Fields of papers citing papers by M. Kazma
This network shows the impact of papers produced by M. Kazma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kazma. The network helps show where M. Kazma may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Kazma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 37 | |
| 2 | 2014 | 24 | |
| 3 | 2014 | 21 | |
| 4 | 2012 | 8 | |
| 5 | 2012 | 66 | |
| 6 | 2012 | 53 | |
| 7 | 2012 | 139 | |
| 8 | 2012 | 17 | |
| 9 | 2011 | 58 | |
| 10 | 2011 | 11 |
About M. Kazma
M. Kazma is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Endocrinology, Clinical Biochemistry and Infectious Diseases, having authored 10 papers that have together received 434 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (8 papers), Urinary Tract Infections Management (3 papers), Enterobacteriaceae and Cronobacter Research (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Antibiotic Use and Resistance (3 papers), Bacterial Identification and Susceptibility Testing (2 papers), Streptococcal Infections and Treatments (2 papers) and Antibiotics Pharmacokinetics and Efficacy (1 paper). The work is most often cited by research in Molecular Medicine (347 citations), Applied Microbiology and Biotechnology (113 citations), Endocrinology (155 citations), Clinical Biochemistry (82 citations) and Critical Care and Intensive Care Medicine (24 citations). M. Kazma has collaborated with scholars based in Israel, Belgium and Poland. Frequent co-authors include Yehuda Carmeli, T. Kotlovsky, Shiri Navon‐Venezia, David A. Schwartz, Vered Schechner, Mitchell J. Schwaber, Hagit Mishali, Christine Lammens, Yaffa Lerman and Herman Goossens. Their work appears in journals such as Clinical Microbiology and Infection, European Journal of Clinical Microbiology & Infectious Diseases, Infection Control and Hospital Epidemiology, PLoS ONE and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.